Literature DB >> 2878509

Glucocorticoid receptor-mediated teratogenesis and cell proliferation in the limbs and face of the chick embryo.

A Pavlík, B Novotná, R Jelínek.   

Abstract

The susceptibility of the face region of the chick embryo to the teratogenic action of intraamniotically injected hydrocortisone contrasts with the resistance of the limbs to its action while at the same time their dysmorphogenesis may be induced by other agents. Since glucocorticoid receptors were shown to mediate face teratogenesis, their development was investigated in freshly dissected limb buds of 3-, 3.5-, and 4-day-old chick embryos in comparison with the face region. The specific binding of 3H-dexamethasone to molybdate-stabilized glucocorticoid receptors was estimated by the dextran-coated charcoal method and complemented by cytologic analysis of mitotic activity in control and hydrocortisone-treated embryos. The glucocorticoid receptors were found in both organ anlagen already on day 3 when their concentration in femtomoles per microgram DNA was significantly higher in the face region. Accordingly, on day 3 intraamniotic hydrocortisone inhibited the mitotic activity in the face without affecting the developing limbs. On days 3.5 and 4 the concentration of glucocorticoid receptors was similar in both organ anlagen. Administration of hydrocortisone on day 4 induced mitotic depression in the face as well as in the limbs. However, the degree of inhibition appeared to be dependent upon the actual mitotic rate. In the face region where the mitotic activity culminated at that time, the inhibition was much deeper and longer-lasting than in the developing limbs characterized by continuous decrease of proliferation rate in controls. These findings are consistent with a view that glucocorticoid receptors are a prerequisite, but not the only factor in receptor-mediated teratogenesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878509     DOI: 10.1002/tcm.1770060510

Source DB:  PubMed          Journal:  Teratog Carcinog Mutagen        ISSN: 0270-3211


  2 in total

1.  In ovo metabolism and yolk glucocorticoid concentration interact to influence embryonic glucocorticoid exposure patterns.

Authors:  Brian G Vassallo; Hannah P Litwa; Mark F Haussmann; Ryan T Paitz
Journal:  Gen Comp Endocrinol       Date:  2018-11-27       Impact factor: 2.822

2.  Systems biology and birth defects prevention: blockade of the glucocorticoid receptor prevents arsenic-induced birth defects.

Authors:  Bhavesh K Ahir; Alison P Sanders; Julia E Rager; Rebecca C Fry
Journal:  Environ Health Perspect       Date:  2013-01-03       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.